Merck KGaA raises 2024 sales forecast to €20.7-€22.1bn, driven by healthcare and electronics performance.
Merck KGaA, Germany's leading pharma company, has raised its 2024 sales forecast to between €20.7bn and €22.1bn due to strong performance in its healthcare and electronics businesses. The company reported net sales of €5.35bn in Q2, which led to an increase in the lower end of its net sales view for the year. Merck's EBITDA before one-time items is now expected to be around €5.8bn to €6.4bn.
July 26, 2024
4 Articles